Off-label use of prasugrel in stable coronary artery disease is associated with greater degree of platelet inhibition compared with use after acute coronary syndrome. - Cuisset, Thomas; Cayla, Guillaume; Quilici, Jacques; Pankert, Mathieu; Deharo, Pierre; Bonnet, Guillaume; Grosdidier, Charlotte; Beguin, Shirley; Morange, Pierre; Bonnet, Jean-Louis; Alessi, Marie-Christine (International Journal of Cardiology, 2013)